What is it about?

There is sometimes uncertainty about who is an author of a paper. When the paper concerns a study with (new) medicines in humans the BJCP has a policy that the doctor looking after the subjects is an author. Some drug companies claim that some doctors are not authors because they do not know anything about the trial. But this is of course strange as this would endanger the trial participants.

Featured Image

Why is it important?

Adequate knowledge of a doctor responsible for a trial is obviously crucial for subject safety. This makes this doctor an automatic author. The BJCP feels this debate has to be out in the open.

Read the Original

This page is a summary of: On authorship in the BJCP , British Journal of Clinical Pharmacology, September 2017, Wiley,
DOI: 10.1111/bcp.13385.
You can read the full text:

Read

Contributors

The following have contributed to this page